ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint747,212 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical companyBaselDrugRekindle GmbH
DrugRekindle GmbH Logo
Verified· 2 sourcesTrust Score
Summary

About the company

DrugRekindle GmbH identifies new therapeutic uses for existing medicines through AI-supported drug repurposing. It connects biomedical and multi-omics evidence, assesses drug candidates through simulations and biological validation, and advances them toward licensing.

AI-generated
Presence

Service area

Offering

Products & services

Industry:Pharmaceutical company
✓ Offered4
Drug Repurposing Platform
Platform for analysing human, biomedical and multi-omics data, identifying new uses for existing drugs, running mechanistic simulations, in silico clinical trials and biological validation.
Licensable Therapeutic Candidates
Identification, ranking and validation of therapeutic candidates based on existing human evidence, focusing on safe-in-human compounds and preparation for licensing to pharma partners.
Research and Validation Partnerships for Pharma and Biotech
Partnerships for pharmaceutical and biotech companies with shelved or under-used drugs, including testing against diseases, validation, defined patient groups and protected IP arrangements.
Investor and Due Diligence Access
Access for investors with data room, technical due diligence and discussions with the Basel team about a repeatable drug-reuse platform.
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
No score yet

DrugRekindle GmbH

Trust & reputation

ranQ Trust Score of DrugRekindle GmbH

Trust Score

No score yet

x

A published score requires a data basis of at least 50% and data from at least two criteria groups other than identity. Missing evidence: Review quality, Review volume, Review recency, Media authority

Data basis 54% · As of November 2026

DrugRekindle GmbH has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
DrugRekindle GmbH scores 40.1 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.0.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
DrugRekindle GmbH scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
DrugRekindle GmbH scores 0.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.0.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%

The data basis is 54%, below the threshold at which ranQ publishes a score. Evidence is missing for: Review quality, Review volume, Review recency, Media authority. As of November 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once DrugRekindle GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

DrugRekindle GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank DrugRekindle GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of DrugRekindle GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Sandgrubenstrasse 44
4058 Basel

At a glance

Legal form
Limited Liability Company
UID
CHE-225.207.251
Founded
2026 · 0 years
Last commercial register change
April 27, 2026
Employees
1 to 10

Similar companies

GG
Galapagos GmbH
Basel
GA
Galvita AG
Basel

Active in 1 of 26 cantons

  • BSBasel-City
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
88.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
  • RI
    Roche International AG
    Basel
    ST
    Skyhawk Therapeutics Europe GmbH
    Basel
    LT
    LifeMine Therapeutics (Switzerland) GmbH
    Basel
    NP
    Noema Pharma AG
    Basel
    AP
    Arakena Pharmaceuticals AG
    Basel
    MB
    Myria Biosciences AG
    Basel
    Full methodology